All News

After last year’s drawn-out flu season, the CDC weighs in on what to expect in 2019-2020

Pharmacies are making the most of tech from automation to big data.

Also indciated to control bleeding and perioperative management.

Immunotherapy drugs combined with stem cell transplantation.

A look at a new study examining the effects of a pipeline drug.

A new law gives pharmacists increased authority.

Why is pharmacy work so stressful, and how can pharmacists take care of that stress?

Injection for leading cause of severe vision loss and legal blindness.

First new treatment of its kind in over 20 years.

Characterized by severe abdominal pain.

Currently only approved for men and transgender women; future trials expected.

Whether marijuana use increases COPD susceptibility remains uncertain.

Only 50% of COPD patients are estimated to be vaccinated.

Which states are the most likely to vaccinate-and which ones are most likely to skip?

The DEA had access to information about where opioids were being sold, but didn’t act on it. Why?

“Historic investment” distributed to private companies, universities, and researchers.

Controlled substance tramadol among the illegally marketed painkillers.

Biosimilars may need more time to devleop in the market.

For granulomatosis with microscopic polyangiitis in children.

Now approved for risk reductions in patients with type 2 diabetes mellitus.

Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.

Biologic medicines could lower spending by $153 billion by 2023.

Several pharmacy groups appealed guideline revisions.

Psoriasis, MS, Lupus, and RA.

A look at some of the exciting drugs that could be approved in the coming months.

Will be part of the U.S.’s public health emergency medical supplies and pharmaceuticals.

Online pharmacy that discovered the impurity discontinues sales.

Some pharmacies are now serving coffee and other refreshments.